Xiaohan Shi

机构：Tang Du Hospital, Air Force Medical University · ORCID：0000-0003-4638-1462

发表论文 74 篇 · 总被引 1211 次 · h-index 19

代表论文

• Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer (2023 · Cell Reports Medicine · 被引 81)
• Proteogenomic characterization of non-functional pancreatic neuroendocrine tumors unravels clinically relevant subgroups (2025 · Cancer Cell · 被引 28)
• A pancreatic cancer organoid biobank links multi-omics signatures to therapeutic response and clinical evaluation of statin combination therapy (2025 · Cell stem cell · 被引 26)
• Detection and characterization of pancreatic and biliary tract cancers using cell-free DNA fragmentomics (2024 · Journal of Experimental & Clinical Cancer Research · 被引 17)
• Early oral feeding versus nasojejunal early enteral nutrition in patients following pancreaticoduodenectomy: a propensity score-weighted analysis of 428 consecutive patients (2023 · International Journal of Surgery · 被引 13)
• Identification and validation of a T cell receptor targeting KRAS G12V in HLA-A*11:01 pancreatic cancer patients (2025 · JCI Insight · 被引 10)